Advertisement
American Family Physician
illustration image image
Cover 2853 2903

Articles


2829
COVER ARTICLE: PRACTICAL THERAPEUTICS
DVT and Pulmonary Embolism: Part I. Diagnosis
PDF Available
About PDFs
DINO W. RAMZI, M.D., C.M., and KENNETH V. LEEPER, M.D.
Approximately 75 percent of patients who develop venous thromboembolism have at least one established risk factor. A well-validated clinical prediction rule can be used to determine the probability of deep venous thrombosis. A clinical prediction rule for pulmonary embolism is most helpful when used in conjunction with subsequent evaluations. CME
   

2841
PRACTICAL THERAPEUTICS
DVT and Pulmonary Embolism: Part II. Treatment and Prevention
PDF Available
About PDFs
DINO W. RAMZI, M.D., C.M., and KENNETH V. LEEPER, M.D.
Unfractionated heparin followed by warfarin is the mainstay of treatment for deep venous thrombosis. Subcutaneously administered low-molecular-weight heparin is as effective as unfractionated heparin. Treatment of pulmonary embolism is similar to that of deep venous thrombosis. CME
   
2853 Spondyloarthropathies
PDF Available
About PDFs
RAJESH K. KATARIA, D.O., and LAWRENCE H. BRENT, M.D.
The spondyloarthropathies are inflammatory arthritides that share certain genetic predisposing factors and clinical features. Inflammatory back pain is common in affected patients, and enthesitis is the basic pathologic lesion. CME
   
2863 Craniosynostosis
PDF Available
About PDFs
HAIDAR KABBANI, M.D., and TALKAD S. RAGHUVEER, M.D.
Craniosynostosis can occur alone or as a syndrome, the most common of which are Apert's syndrome and Crouzon's disease. The diagnosis relies on physical examination, plain radiography, and computed tomography.CME
   
2875 Metabolic Syndrome: Time for Action
PDF Available
About PDFs
DARWIN DEEN, M.D., M.S.
Metabolic syndrome will soon become the number one risk factor for heart disease. Effective interventions include diet, exercise, and judicious use of pharmacologic agents to address specific risk factors such as abdominal obesity, high blood pressure, insulin resistance, and lipid abnormalities. CME
Patient information: "Matablic Syndrome: What Is It and What Can I Do About It?" p.2887
   

Departments

2741 Inside AFP
2745 Strength of Recommendation Taxonomy in AFP
2749 Newsletter
2753 Quantum Sufficit
2757 Clinical Quiz
2764 Letters to the Editor
2776 Editorials

"AAP, AAFP, AAO-HNS Release Guideline on Diagnosis and Management of Otitis Media with Effusion," p. 2929

2785 CME Calendar
2814 Diary from a Week in Practice
2822

Cochrane for Clinicians: Putting Evidence into Practice

COCHRANE BRIEFS
2891 U.S. Preventive Services Task Force: Recommendation Statement
  • Screening for Coronary Heart Disease
2895 Levels-of-Evidence Labels in AFP
2896 Point-of-Care Guides
  • Acute Otitis Media in Children
2901 STEPS
  • Tiotropium (Spiriva) for COPD
2903 Photo Quiz
2905 POEMs and Tips from Other Journals
2912 Definition of POEMs
2929 Practice Guidelines
  • AAP, AAFP, AAO-HNS Release Guideline on Diagnosis and Management of Otitis Media with Effusion

Editorial: "Otitis Media with Effusion Clinical Practice Guideline," p. 2776

2933 Clinical Briefs
2935 Change-of-Address Form
2937 Classified Information
  Information for Authors

Cover illustration © 2004 Michael Kress-Russick, Madison, Wis.



Advertisement